Dataset Information


Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humans.

ABSTRACT: The immunologic basis for the potential enhanced HIV-1 acquisition in adenovirus serotype 5 (Ad5)-seropositive individuals who received the Merck recombinant Ad5 HIV-1 vaccine in the STEP study remains unclear. Here we show that baseline Ad5-specific neutralizing antibodies are not correlated with Ad5-specific T lymphocyte responses and that Ad5-seropositive subjects do not develop higher vector-specific cellular immune responses as compared with Ad5-seronegative subjects after vaccination. These findings challenge the hypothesis that activated Ad5-specific T lymphocytes were the cause of the potential enhanced HIV-1 susceptibility in the STEP study.

PROVIDER: S-EPMC2756115 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC2723179 | BioStudies
| S-EPMC3008674 | BioStudies
| S-EPMC3319553 | BioStudies
| S-EPMC8357155 | BioStudies
| S-EPMC3076372 | BioStudies
| E-GEOD-22822 | BioStudies
2012-11-20 | E-GEOD-22822 | ArrayExpress
| S-EPMC4121165 | BioStudies
2012-11-20 | E-GEOD-22769 | ArrayExpress
2008-01-01 | S-EPMC2585831 | BioStudies